# Exelixis, Inc. – FDA Inspection, May 5, 2026

Source: https://www.keypedia.com/records/fda_inspections/exelixis-inc/d1b3bb11-6beb-4455-89a0-921c99e321ad
Source feed: FDA_Inspections

> FDA inspection 1319178 of Exelixis, Inc., May 05, 2026. 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1319178
- Company Name: Exelixis, Inc.
- Inspection Date: 2026-05-05
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1049904 - 2018-03-27
- [FDA Inspection 802660 - 2012-09-27](https://www.keypedia.com/records/fda_inspections/exelixis-inc/bbb20d10-bf47-4cff-aab3-107f6afff8a5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/cynthia-j-tsui/e02b5fd2-e90b-47a7-bbc2-e658f160c4ae)

Company: https://www.keypedia.com/companies/exelixis-inc/9bd9218c-af48-40bb-a20d-bd3e4fb4f674

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df